Track the INTENSITY THERAPEUTICS, INC. share price and the full insider trade history of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Market capitalisation: €12m. The latest transaction was reported on 30 March 2026 (Attribution). Among the most active insiders: Wesolowski John M. Every trade is free.
6
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
30Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
1,000 shares@ US$4.00100.0% of flowCommon Stock, $0.0001 Par ValueSEC:0001895944-24-000011:0
6 of 6 declarations
About INTENSITY THERAPEUTICS, INC.
INTENSITY THERAPEUTICS, INC. is a biopharmaceutical company focused on developing innovative cancer treatments. It is listed on the NASDAQ under the ticker symbol INTZ.